Periodontal Therapeutics Market - Size and Share 2031
The Periodontal Therapeutics Market is expected to register a CAGR of 7.6% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The Periodontal Therapeutics Market report covers analysis By Drug Type (Arestin, Atridox, Doxycycline, Metronidazole, Minocycline, Periochip, Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Channel) , and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Periodontal Therapeutics Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Periodontal Therapeutics Market Segmentation
Drug Type- Arestin
- Atridox
- Doxycycline
- Metronidazole
- Minocycline
- Periochip
- Hospital Pharmacies
- Retail Pharmacies
- Online Channel
Strategic Insights
Periodontal Therapeutics Market Growth Drivers- Rising Incidence of Periodontal Diseases:
The increasing prevalence of periodontal diseases, such as gingivitis and periodontitis, especially among aging populations and individuals with risk factors like smoking, diabetes, and poor oral hygiene, is a key driver. As these conditions affect a large portion of the global population, there is a growing demand for effective periodontal therapeutics.
- Growing Awareness of Oral Health:
As public awareness about the link between oral health and overall health continues to rise, more individuals are seeking treatment for periodontal diseases. Recognizing the connection between periodontal disease and systemic conditions like heart disease, diabetes, and stroke is prompting increased focus on treatment options.
- Technological Advancements in Treatment Options:
Advancements in periodontal therapeutics, including the development of laser therapies, regenerative treatments, and advanced biomaterials, are enhancing treatment efficacy and patient outcomes. These innovations are driving market growth by offering more effective and less invasive options for managing periodontal diseases.
- Integration of Regenerative Therapies:
The emerging trends in the periodontal therapeutics market include regenerative therapies, including the use of growth factors, stem cell-based treatments, and tissue engineering. Such therapies aim to regenerate lost tissue and bone, hence providing long-term benefits to patients with severe periodontal disease and improving the quality of life.
- Increased Adoption of Advanced Diagnostic Tools:
The integration of advanced diagnostic tools such as digital imaging, genetic testing, and salivary biomarkers is enhancing the diagnosis accuracy of periodontal disease. Early diagnosis will allow for more targeted treatment plans, which are the factors driving the growth of the market.
- Personalized Periodontal Care:
Personalized treatments based on an individual's specific oral health needs, genetic makeup, and risk factors are increasingly being adopted. Personalized care ensures better outcomes because it addresses the root causes of periodontal disease and selects the most effective treatment options.
- Innovation in Combination Therapies:
There is an opportunity to develop combination therapies that target multiple aspects of periodontal disease, such as antimicrobial treatments combined with regenerative therapies. Combination approaches can provide more holistic treatment options for patients, thereby improving both short-term and long-term outcomes.
- Growing Demand for Aesthetic Dentistry:
While aesthetics dentistry continues gaining traction, the need for therapeutic treatments is also high due to not only healing diseases of the periodontium but also the cosmetic view of the gums and their appearance and color together with the color and shade of their teeth. This demand opportunity stands a chance to create home-care and digital dentistry innovation spaces.
- Advancement in Telehealth: With the advancements in telehealth and at-home dental care solutions, periodontal therapeutics will gain the opportunity to expand into the realm of home care products. Advanced oral care products and digital platforms that enable remote monitoring are sure to become increasingly popular at home for the support of periodontal health.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Periodontal Therapeutics Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Periodontal Therapeutics Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Periodontal Therapeutics Market is estimated to witness a CAGR of 7.6% from 2023 to 2031.
The major factors driving the market are: Increasing awareness of oral health, Technological advancements in treatments, Rising prevalence of periodontal diseases
Key future trends in this market are - Increased Oral Health Awareness, Aging Population, Technological Advancements
Key companies of this market are: Tolmar Pharmaceuticals, Inc., Eli Lilly and Company, Align Technology, Inc., 3M, Ultradent Products Inc., Nobel Biocare Services AG, Glidewell Laboratories, Den-Mat Holdings, LLC, Mallinckrodt, Teva Pharmaceutical Industries Ltd.
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Periodontal Therapeutics Market - By Drug Type
1.3.2 Periodontal Therapeutics Market - By Distribution Channel
1.3.3 Periodontal Therapeutics Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PERIODONTAL THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PERIODONTAL THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. PERIODONTAL THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. PERIODONTAL THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. PERIODONTAL THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. PERIODONTAL THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. ARESTIN
7.3.1. Overview
7.3.2. Arestin Market Forecast and Analysis
7.4. ATRIDOX
7.4.1. Overview
7.4.2. Atridox Market Forecast and Analysis
7.5. DOXYCYCLINE
7.5.1. Overview
7.5.2. Doxycycline Market Forecast and Analysis
7.6. METRONIDAZOLE
7.6.1. Overview
7.6.2. Metronidazole Market Forecast and Analysis
7.7. MINOCYCLINE
7.7.1. Overview
7.7.2. Minocycline Market Forecast and Analysis
7.8. PERIOCHIP
7.8.1. Overview
7.8.2. Periochip Market Forecast and Analysis
7.9. OTHERS
7.9.1. Overview
7.9.2. Others Market Forecast and Analysis
8. PERIODONTAL THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
8.5. ONLINE CHANNEL
8.5.1. Overview
8.5.2. Online Channel Market Forecast and Analysis
9. PERIODONTAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Periodontal Therapeutics Market Overview
9.1.2 North America Periodontal Therapeutics Market Forecasts and Analysis
9.1.3 North America Periodontal Therapeutics Market Forecasts and Analysis - By Drug Type
9.1.4 North America Periodontal Therapeutics Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Periodontal Therapeutics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Periodontal Therapeutics Market
9.1.5.1.1 United States Periodontal Therapeutics Market by Drug Type
9.1.5.1.2 United States Periodontal Therapeutics Market by Distribution Channel
9.1.5.2 Canada Periodontal Therapeutics Market
9.1.5.2.1 Canada Periodontal Therapeutics Market by Drug Type
9.1.5.2.2 Canada Periodontal Therapeutics Market by Distribution Channel
9.1.5.3 Mexico Periodontal Therapeutics Market
9.1.5.3.1 Mexico Periodontal Therapeutics Market by Drug Type
9.1.5.3.2 Mexico Periodontal Therapeutics Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Periodontal Therapeutics Market Overview
9.2.2 Europe Periodontal Therapeutics Market Forecasts and Analysis
9.2.3 Europe Periodontal Therapeutics Market Forecasts and Analysis - By Drug Type
9.2.4 Europe Periodontal Therapeutics Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Periodontal Therapeutics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Periodontal Therapeutics Market
9.2.5.1.1 Germany Periodontal Therapeutics Market by Drug Type
9.2.5.1.2 Germany Periodontal Therapeutics Market by Distribution Channel
9.2.5.2 France Periodontal Therapeutics Market
9.2.5.2.1 France Periodontal Therapeutics Market by Drug Type
9.2.5.2.2 France Periodontal Therapeutics Market by Distribution Channel
9.2.5.3 Italy Periodontal Therapeutics Market
9.2.5.3.1 Italy Periodontal Therapeutics Market by Drug Type
9.2.5.3.2 Italy Periodontal Therapeutics Market by Distribution Channel
9.2.5.4 Spain Periodontal Therapeutics Market
9.2.5.4.1 Spain Periodontal Therapeutics Market by Drug Type
9.2.5.4.2 Spain Periodontal Therapeutics Market by Distribution Channel
9.2.5.5 United Kingdom Periodontal Therapeutics Market
9.2.5.5.1 United Kingdom Periodontal Therapeutics Market by Drug Type
9.2.5.5.2 United Kingdom Periodontal Therapeutics Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Periodontal Therapeutics Market Overview
9.3.2 Asia-Pacific Periodontal Therapeutics Market Forecasts and Analysis
9.3.3 Asia-Pacific Periodontal Therapeutics Market Forecasts and Analysis - By Drug Type
9.3.4 Asia-Pacific Periodontal Therapeutics Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Periodontal Therapeutics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Periodontal Therapeutics Market
9.3.5.1.1 Australia Periodontal Therapeutics Market by Drug Type
9.3.5.1.2 Australia Periodontal Therapeutics Market by Distribution Channel
9.3.5.2 China Periodontal Therapeutics Market
9.3.5.2.1 China Periodontal Therapeutics Market by Drug Type
9.3.5.2.2 China Periodontal Therapeutics Market by Distribution Channel
9.3.5.3 India Periodontal Therapeutics Market
9.3.5.3.1 India Periodontal Therapeutics Market by Drug Type
9.3.5.3.2 India Periodontal Therapeutics Market by Distribution Channel
9.3.5.4 Japan Periodontal Therapeutics Market
9.3.5.4.1 Japan Periodontal Therapeutics Market by Drug Type
9.3.5.4.2 Japan Periodontal Therapeutics Market by Distribution Channel
9.3.5.5 South Korea Periodontal Therapeutics Market
9.3.5.5.1 South Korea Periodontal Therapeutics Market by Drug Type
9.3.5.5.2 South Korea Periodontal Therapeutics Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Periodontal Therapeutics Market Overview
9.4.2 Middle East and Africa Periodontal Therapeutics Market Forecasts and Analysis
9.4.3 Middle East and Africa Periodontal Therapeutics Market Forecasts and Analysis - By Drug Type
9.4.4 Middle East and Africa Periodontal Therapeutics Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Periodontal Therapeutics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Periodontal Therapeutics Market
9.4.5.1.1 South Africa Periodontal Therapeutics Market by Drug Type
9.4.5.1.2 South Africa Periodontal Therapeutics Market by Distribution Channel
9.4.5.2 Saudi Arabia Periodontal Therapeutics Market
9.4.5.2.1 Saudi Arabia Periodontal Therapeutics Market by Drug Type
9.4.5.2.2 Saudi Arabia Periodontal Therapeutics Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Periodontal Therapeutics Market Overview
9.5.2 South and Central America Periodontal Therapeutics Market Forecasts and Analysis
9.5.3 South and Central America Periodontal Therapeutics Market Forecasts and Analysis - By Drug Type
9.5.4 South and Central America Periodontal Therapeutics Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Periodontal Therapeutics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Periodontal Therapeutics Market
9.5.5.1.1 Brazil Periodontal Therapeutics Market by Drug Type
9.5.5.1.2 Brazil Periodontal Therapeutics Market by Distribution Channel
9.5.5.2 Argentina Periodontal Therapeutics Market
9.5.5.2.1 Argentina Periodontal Therapeutics Market by Drug Type
9.5.5.2.2 Argentina Periodontal Therapeutics Market by Distribution Channel
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. PERIODONTAL THERAPEUTICS MARKET, KEY COMPANY PROFILES
11.1. TOLMAR PHARMACEUTICALS, INC
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ELI LILLY AND COMPANY
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ALIGN TECHNOLOGY, INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. 3M
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. ULTRADENT PRODUCTS INC.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. NOBEL BIOCARE SERVICES AG
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. GLIDEWELL LABORATORIES
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. DEN-MAT HOLDINGS, LLC
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. MALLINCKRODT.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. TEVA PHARMACEUTICAL INDUSTRIES LTD
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. Tolmar Pharmaceuticals, Inc.
2. Eli Lilly and Company
3. Align Technology, Inc.
4. 3M
5. Ultradent Products Inc.
6. Nobel Biocare Services AG
7. Glidewell Laboratories
8. Den-Mat Holdings, LLC
9. Mallinckrodt.
10. Teva Pharmaceutical Industries Ltd
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For